|
Scientific advisory board
We are delighted to announce our official Scientific Advisory Board for this year’s event.
The World Vaccines Congress Washington was developed with input from a team of internationally recognised professionals in the vaccines community. Terrapinn would like to thank the following members of the scientific advisory board for help in creating this congress.
Scientific Board Members include:
- Dr Lance Gordon, Former President and Chief Executive Officer Vaxgen, Independent Advisor
- Kim Bush, President, Vaccines SBU, Baxter Vaccines
- Dr Una Ryan, President and Chief Executive Officer, AVANT Immunotherapeutics
- Dr Allan Jarvis, Senior Vice President, Corporate Development, sanofi pasteur
- Dr Daniel Tusé, Vice President, Business Development, Large Scale Biology Corporation
- Jacques-Francois Martin, President, Parteurop
- Ruth Levine, Director of Programmes and Senior Fellow, Center for Global Development
- Dr Ronald Ellis, Senior Vice President, Research & Development, AVANT Immunotherapeutics
There are still opportunities for you to join our official scientific advisory board. To apply please email neil.darkes@terrapinn.com
 Dr Lance GordonFormer President and Chief Executive Officer Vaxgen
Independent Advisor
Dr Gordon has 25 years of experience in the industry, developing both vaccine products and companies. Prior to joining VaxGen, Dr Gordon served as Chief Executive Officer and a member of the Board of Directors of two vaccine companies, OraVax (now Acambis, Inc.) and North American Vaccines (now Baxter BioScience). At OraVax, Dr Gordon secured a contract to develop, manufacture, store, and manage a stockpile of smallpox vaccine for the Centers for Disease Control.
 Kim BushPresident, Vaccines SBU
Baxter Vaccines
Kim Bush joined Baxter International in 1978 and currently holds the position of President, Baxter BioScience, Vaccines Division. He and his team are responsible for the commercial management of Baxter’s vaccine business on a global basis. Prior to holding this position, Kim held several Baxter senior management positions including, President, Hyland Immuno Europe, President, Biotech Europe and President of Baxter’s Fenwal Division. The Biomedical Division of Allegiance Healthcare Corporation.
 Dr Una RyanPresident and Chief Executive Officer
AVANT Immunotherapeutics
Dr Ryan is President and Chief Executive Officer of AVANT Immunotherapeutics, Inc. She is also Research Professor of Medicine at the Whitaker Cardiovascular Institute of Boston University School of Medicine, serves on the Whitehead Institute Board of Associates and is Chair of the Massachusetts Biotechnology Council.
 Dr Allan JarvisSenior Vice President, Corporate Development
sanofi pasteur
Allan Jarvis is currently Senior Vice President, Corporate Development at sanofi pasteur, a division of Aventis Pharmaceuticals. In that capacity he is responsible for the business development, strategic planning and process efficiency and cost effectiveness functions. He oversees AvP’s worldwide Corporate Development function and is responsible for managing the company’s growth through alliances, joint ventures, partnerships, mergers, acquisitions, and the licensing of products and technology.
 Dr Daniel TuséVice President, Business Development
Large Scale Biology Corporation
Daniel Tusé is responsible for business development functions and for helping co-ordinate strategic planning and product development programmes. Before joining LSBC, he was Assistant Director of the Life Sciences Division at SRI International. Prior to that, he held a number of research management positions.
 Jacques-Francois MartinPresident
Parteurop
Jacques-François Martin has spent the essence of his career in the pharmaceutical, biological and life sciences industries. He set up Parteurop S.A., as Chairman and Chief Executive Officer, he helps establish start-up companies by leveraging innovation from French and foreign institutions. From 2000 to January 2005, Martin held the position of President of The Vaccine Fund.
 Ruth LevineDirector of Programmes and Senior Fellow
Center for Global Development
Ruth Levine is a health economist with 15 years of experience working on health and family planning financing issues in Latin America, Eastern Africa, the Middle East, and South Asia. At CGD, she sets priorities and manages programs that use research to address practical policy challenges; she manages the Global Health Policy Research Network. Before joining the center, Ruth designed, supervised, and evaluated health sector loans at the World Bank and the Inter-American Development Bank.
 Dr Ronald EllisSenior Vice President, Research & Development
AVANT Immunotherapeutics
Ronald Ellis joined AVANT in January 2006 as Senior Vice President, Research & Development. He spent 14 years at Merck Research Laboratories, where he became responsible for preclinical vaccine research and was co-chairman of collaborations in developing pediatric combination vaccines with partner companies. He joined Astra Research Center Boston in 1996 and directed their vaccine program. He then joined BioChem Pharma in 1998 to set up a Boston-area vaccine development subsidiary, and continued as Senior Vice President Development through purchases by Shire Pharmaceuticals in 2001 and then by ID Biomedical in September 2004.
|
